bonyf News | finanzen.ch

bonyf Aktie VALOR 116822360 / ISIN BE6333353298

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Trading-Depot

Aktion

Portfolio

Watchlist

05.09.25	bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments (EQS Group)
11.08.25	Periocream: The Future Commercial Winner for bonyf (EQS Group)
14.07.25	bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility (EQS Group)
30.06.25	Annual Results 2024 (EQS Group)
03.06.25	bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India (EQS Group)
15.05.25	bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy (EQS Group)
08.04.25	bonyf Advances to Phase 3 in the Development of Alginate-Organic Denture Fixative Cream (EQS Group)
13.03.25	bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne (EQS Group)
18.02.25	bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy (EQS Group)
30.01.25	bonyf R&D presents its two latest innovations at IDS 2025 in Cologne (EQS Group)
10.12.24	bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market (EQS Group)
09.12.24	bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions (EQS Group)
28.11.24	bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India (EQS Group)
24.10.24	PerioTabs Innovative 10-Day NitrAdine-Based Treatment to Revolutionize Oral Care (EQS Group)
03.09.24	bonyf's Advanced Skincare Formula Offers Fast Relief for Heel and Finger Cracks (EQS Group)
09.08.24	NitrAdine Dental Effervescent Tabs: Revolutionizing dental hygiene with unrivalled disinfecting power (EQS Group)
18.07.24	Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives (EQS Group)
28.06.24	bonyf NV: bonyf's 2023 financial statements made available (EQS Group)
07.06.24	Advanced R&D capabilities and proven efficacy of our unique fast pain-relief mouth ulcer cream (EQS Group)
10.05.24	2024 Sales Forecast: Unprecedented Growth on the Horizon (EQS Group)
16.04.24	bonyf exhibits at PLMA Amsterdam on 28-29 May 2024 (EQS Group)
04.04.24	bonyf Advances to Phase 2 in Development of Alginate-Organic Denture Fixative Cream (EQS Group)

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Kuehne+Nagel Int	166.85	1.86 %	K V
ABB	55.94	1.56 %	K V
Holcim	67.60	1.11 %	K V
Sika	187.20	0.97 %	K V
Nestle	74.72	-0.92 %	K V
Lonza Grp	570.20	-1.25 %	K V
Alcon	63.20	-1.37 %	K V
Roche Hldg G	270.10	-1.50 %	K V
Novartis	102.32	-1.60 %	K V